These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34475098)

  • 1. Hepatocytic Activating Transcription Factor 3 Protects Against Steatohepatitis via Hepatocyte Nuclear Factor 4α.
    Xu Y; Hu S; Jadhav K; Zhu Y; Pan X; Bawa FC; Yin L; Zhang Y
    Diabetes; 2021 Nov; 70(11):2506-2517. PubMed ID: 34475098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice).
    Xu Y; Zhu Y; Hu S; Xu Y; Stroup D; Pan X; Bawa FC; Chen S; Gopoju R; Yin L; Zhang Y
    Hepatology; 2021 Jun; 73(6):2251-2265. PubMed ID: 33098092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Krüppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4α-mediated metabolic pathways.
    Pan X; Hu S; Xu Y; Gopoju R; Zhu Y; Cassim Bawa FN; Wang H; Wang J; Batayneh Z; Clark A; Zeng Y; Lin L; Wang X; Yin L; Zhang Y
    Metabolism; 2024 Jun; 155():155909. PubMed ID: 38582490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism.
    Xu Y; Li Y; Jadhav K; Pan X; Zhu Y; Hu S; Chen S; Chen L; Tang Y; Wang HH; Yang L; Wang DQ; Yin L; Zhang Y
    Nat Metab; 2021 Jan; 3(1):59-74. PubMed ID: 33462514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atf3-mediated metabolic reprogramming in hepatic macrophage orchestrates metabolic dysfunction-associated steatohepatitis.
    Hu S; Li R; Gong D; Hu P; Xu J; Ai Y; Zhao X; Hu C; Xu M; Liu C; Chen S; Fan J; Zhao Z; Zhang Z; Wu H; Xu Y
    Sci Adv; 2024 Jul; 10(30):eado3141. PubMed ID: 39047111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High fat diet-induced oxidative stress blocks hepatocyte nuclear factor 4α and leads to hepatic steatosis in mice.
    Yu D; Chen G; Pan M; Zhang J; He W; Liu Y; Nian X; Sheng L; Xu B
    J Cell Physiol; 2018 Jun; 233(6):4770-4782. PubMed ID: 29150932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte-specific expression of human carboxylesterase 2 attenuates nonalcoholic steatohepatitis in mice.
    Xu Y; Pan X; Hu S; Zhu Y; Cassim Bawa F; Li Y; Yin L; Zhang Y
    Am J Physiol Gastrointest Liver Physiol; 2021 Jan; 320(2):G166-G174. PubMed ID: 33325808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
    Zhang H; Shen Z; Lin Y; Zhang J; Zhang Y; Liu P; Zeng H; Yu M; Chen X; Ning L; Mao X; Cen L; Yu C; Xu C
    J Biol Chem; 2020 Mar; 295(12):3891-3905. PubMed ID: 32051143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3.
    Fang J; Ji YX; Zhang P; Cheng L; Chen Y; Chen J; Su Y; Cheng X; Zhang Y; Li T; Zhu X; Zhang XJ; Wei X
    Hepatology; 2020 May; 71(5):1592-1608. PubMed ID: 31529495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice.
    Li Y; Zalzala M; Jadhav K; Xu Y; Kasumov T; Yin L; Zhang Y
    Hepatology; 2016 Jun; 63(6):1860-74. PubMed ID: 26806650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease.
    Pan X; Zhang Y
    Chin Med J (Engl); 2022 May; 135(10):1172-1181. PubMed ID: 35191422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hepatocyte nuclear factor 4α in controlling copper-responsive transcription.
    Song MO; Freedman JH
    Biochim Biophys Acta; 2011 Jan; 1813(1):102-8. PubMed ID: 20875833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of ATF3 gene network by triglyceride-rich lipoprotein lipolysis products increases vascular apoptosis and inflammation.
    Aung HH; Lame MW; Gohil K; An CI; Wilson DW; Rutledge JC
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2088-96. PubMed ID: 23868936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
    Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
    J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxylesterase 1 Is Regulated by Hepatocyte Nuclear Factor 4α and Protects Against Alcohol- and MCD diet-induced Liver Injury.
    Xu J; Xu Y; Li Y; Jadhav K; You M; Yin L; Zhang Y
    Sci Rep; 2016 Apr; 6():24277. PubMed ID: 27075303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism.
    Xu Y; Zalzala M; Xu J; Li Y; Yin L; Zhang Y
    Nat Commun; 2015 Jun; 6():7466. PubMed ID: 26100857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte nuclear factor 4α induces a tendency of differentiation and activation of rat hepatic stellate cells.
    Liu K; Guo MG; Lou XL; Li XY; Xu Y; Ji WD; Huang XD; Yang JH; Duan JC
    World J Gastroenterol; 2015 May; 21(19):5856-66. PubMed ID: 26019449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transcription factor ATF3 switches cell death from apoptosis to necroptosis in hepatic steatosis in male mice.
    Inaba Y; Hashiuchi E; Watanabe H; Kimura K; Oshima Y; Tsuchiya K; Murai S; Takahashi C; Matsumoto M; Kitajima S; Yamamoto Y; Honda M; Asahara SI; Ravnskjaer K; Horike SI; Kaneko S; Kasuga M; Nakano H; Harada K; Inoue H
    Nat Commun; 2023 Jan; 14(1):167. PubMed ID: 36690638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiolipin Synthase 1 Ameliorates NASH Through Activating Transcription Factor 3 Transcriptional Inactivation.
    Tu C; Xiong H; Hu Y; Wang W; Mei G; Wang H; Li Y; Zhou Z; Meng F; Zhang P; Mei Z
    Hepatology; 2020 Dec; 72(6):1949-1967. PubMed ID: 32096565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
    Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
    Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.